-- 沙特阿拉伯交易所交易的股票本周收高，受沙特阿拉伯商业信心增强的提振，沙特综合指数（Tadawul All Share Index）周四上涨0.75%。 据沙特统计总局发布的报告显示，沙特4月份商业信心指数升至54.5，高于3月份的52.1。报告期内，工业、建筑业和服务业的信心指数也均有所上升。 此外，美国和伊朗冲突有望结束也提振了市场情绪。路透社援引一位巴基斯坦消息人士的话报道称，双方正在努力达成一项临时协议，以稳定霍尔木兹海峡局势，并防止冲突再次爆发。 “有关美伊和平协议的报道越来越可信，巴基斯坦外交部表示预计‘很快’就能达成解决方案，而华盛顿方面则预计伊朗将在48小时内做出回应。即便达成协议，Rystad Energy也警告称，其对现货石油市场的影响将比目前期货价格反映的更为缓慢且更具不确定性，”Rystad Energy在一份报告中指出。“这并非解决方案，而只是结构性的暂停，这一区别对现货原油市场至关重要。” 在国内，又一批财报陆续发布。沙特公共交通公司（SASE:4040，简称Saptco）和灌装包装材料制造公司（SASE:2180，简称Fipco）在截至3月31日的三个月内扭亏为盈。然而，中东纸业公司（SASE:1202，简称Mepco）在3月份的季度中却出现亏损。 Saptco 和 Mepco 分别下跌 10% 和 0.28%，而 Fipco 则上涨 2%。 与此同时，国家学习与教育公司 (SASE:4291)（简称 NCLE）股价小幅下跌 0.75%，原因是该公司获得了总额达 2.3 亿沙特里亚尔的长期和短期符合伊斯兰教法的信贷额度。这笔资金将用于其扩张计划。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO